The global pharmaceutical vials market is expected to be valued at USD 12,137.2 million in 2023 and reach a valuation of USD 24,099.7 million by 2033. The demand for pharmaceutical vials is estimated to grow at a steady 7.10% CAGR, with the United Kingdom, the USA, China, and India emerging as key producers.
The market for pharmaceutical vials has seen increased demand as a result of the rise in requirements for pharmaceutical products. Advances in pharmaceutical packaging have accelerated the adoption of environmentally friendly materials. One class of materials that has gained popularity is Type I molded glass vials, largely because of their exceptional chemical makeup.
Numerous significant developments in the healthcare sector are creating new demand potential for pharmaceutical vials. The popularity of pharmaceutical vials has also been boosted by healthcare professionals and care takers' emphasis on making sure that patients take the right dosage of medication.
The market for manufacturers in the biotechnology and pharmaceutical sectors has benefited from the demand for new formulations for chronic diseases in hospitalized patients.
Vials and ampoules are expected to grow, primarily due to increased consumption from emerging markets like China and India, as a result of the complexity of drugs and the rise in diseases like diabetes. About 422 million people worldwide have diabetes, according to the World Health Organization (WHO).
Additionally, the use of glass vials is anticipated to increase over the forecast period as a result of factors like the rise in medical care costs caused by improper medication consumption and the growing propensity of different end-users, including hospitals and drug manufacturers.
During the coronavirus outbreak, market vendors tried their best to assist as much as they could. For example, Corning provided its products, such as glass tubing for diagnostic test kits and vials for vaccine clinical drug trials, to provide corning valor glass packaging and fill the gap for the anticipated drug shortages.
Additionally, the business added glass packaging and any consumable requirements from its Life Sciences portfolio for vaccine process development.
| Attributes | Details |
|---|---|
| Pharmaceutical Vials Market CAGR (2023 to 2033) | 7.10% |
| Pharmaceutical Vials Market Size (2023) | USD 12137.2 million |
| Pharmaceutical Vials Market Size (2033) | USD 24,099.7 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Increasing demand for parenteral drugs has been a key factor enabling the expansion of the pharmaceutical vials market in recent years. Between 2016 and 2020, the market grew at around 8% CAGR, says Future Market Insights (FMI) in its recent report.
| Particulars | Details |
|---|---|
| Jan-Jun (H1), 2021 (A) | 7.50% |
| Jan-Jun (H1), 2022 Projected (P) | 7.30% |
| Jan-Jun (H1), 2022 Outlook (O) | 7.70% |
| BPS: H1,2022 (O) - H1,2022 (P) | 20 |
| BPS: H1,2022 (O) - H1,2021 (P) | 40 |
Short-term growth (2023 to 2026): National Cancer Institute reports that in 2020, around 1.8 million new cancer cases were diagnosed in the USA. Rise of new cancer cases across the globe has further elevated the demand for pharmaceutical vials, especially for chemotherapy drugs.
In June 2021, Zydus Cadila Healthcare received tentative approval from the USA Food and Drug Administration (FDA) to market and sell pemetrexed in 100mg/vial, 500 mg/vial, and 1000 mg/vial, and single-dose vials for injection. Pemetrexed is a chemotherapy drug and is found effective in slowing or stopping the growth of cancer cells.
Medium-term growth (2027 to 2030): Unprecedented outbreak of the COVID-19 pandemic has increased the demand for parenteral drugs, encouraging market players to develop new pharmaceutical vials that are safe, sterile, and remain contamination free before administration. This is expected to create lucrative growth opportunities for the market.
Responding to the high demand for COVID-19 parenteral drugs, in 2021, SGD Pharma launched its new ready-to-use 20ml EasyLyo molded glass Type I vials packed in its modern secondary packaging format called “SG EZ-fill® Nest & Tub.”
The company claims that this new primary and secondary packaging combination is likely to offer biopharmaceutical producers the necessary flexibility in terms of delivering innovative medicines to patients at a faster rate.
Long-term growth (2031 to 2033): Increasing vaccination drives and high demand for parenteral drugs like insulin and corticosteroids are expected to drive the demand for pharmaceutical vials globally in the forthcoming decade.
Pharmaceutical vials are a type of small containers that are used for the purpose of storing liquid medications. They are made up of plastic or glass and are mainly used for unit dose packaging of medications. Pharmaceutical vials also help patients in consuming their medications in the right dosage and at the right time.
Ever since the last few decades, low medical adherence by patients has posed a critical situation for the healthcare industry as it involves the safety of the patients and causes increased healthcare spending.
To solve these issues, the healthcare industry is making constant efforts to improve the intake of medications by patients and ensure that the patients take the right dosage of drugs at the right time. In this process, the packaging of drugs and various medicines plays an important part.
Particularly in the United States, it has been reported that around 50 percent of the prescribed medications are taken incorrectly by patients. In addition, in an independent study, it was found that since patients don’t take their medications in the right manner, there are increased medical costs to the tune of USD 200 billion.
Due to this situation, there is a demand created for such kind of pharmaceutical products that contain medications in such form that can be easily taken by the patients. This helps the patients to take the right dosage of medicines at the correct time, thus reducing their time of recovery and reducing the burden on the healthcare system as well.
Principal Consultant
The demand for injectable drugs is growing due to the increasing prevalence of chronic diseases such as cancer and diabetes. As vials are a popular choice for packaging and delivering injectable drugs, this is driving the demand for pharmaceutical vials in the USA market.
There is a growing emphasis on safety and compliance in the pharmaceutical industry, driven by regulatory requirements, as well as the desire to reduce medication errors and improve patient outcomes. This is driving the demand for high-quality pharmaceutical vials that can ensure the safe and accurate delivery of medications.
Technological advancements in the production of vials, such as the use of automation and robotics, are creating new opportunities for manufacturers to produce high-quality vials at a faster rate while reducing costs. The trend toward personalized medicine is driving the demand for customized vials that can accommodate specific dosages and delivery requirements.
Overall, these factors are contributing to the growth of the pharmaceutical vials market in the United States and are expected to continue to do so in the coming years.
China is the second-largest market for pharmaceuticals globally, and it is expected to expand significantly in the upcoming years. The rising demand for medications in China is leading to an increased requirement for pharmaceutical packaging, which includes vials. There is a growing need for superior quality packaging products, including vials, as the Chinese pharmaceutical sector is developing and becoming more mature. This is because it is essential to guarantee that medications are safe and effective, and that they meet regulatory requirements.
The Chinese government has implemented policies to promote the growth of the pharmaceutical industry, such as offering tax incentives and making regulatory procedures efficient. As a result, this is making it easier for manufacturers of pharmaceutical packaging, including vials, to operate in a more favorable environment.
China's middle class is expanding, which is driving the demand for high-quality healthcare products, including medicines and packaging. This presents an opportunity for manufacturers of pharmaceutical vials to offer premium and valuable products.
The pharmaceutical vials market is expected to continue to offer lucrative opportunities, and Asia Pacific is expected to play a significant role in their expansion. Outstanding developments in the pharmaceutical manufacturing sector in emerging economies, particularly India, have prodded businesses to extend their supply chains there. Over the years, the expansion of hospitals and pharmaceutical companies in those economies has increased the regional market's potential for revenue.
India is a desirable market for pharmaceutical packaging manufacturers seeking to cut costs while maintaining high standards because it has historically had lower labor and production costs than other nations. The demand for pharmaceutical packaging, including vials, is anticipated to increase further as a result of India's expanding pharmaceutical export market, opening up new business opportunities for suppliers.
The plastic sub-segment in the material type category is anticipated to grow at a robust growth rate and register a CAGR of 5.1% during the period of assessment. This is a highly lucrative segment in the material type category.
As per the projections of Future Market Insights, the plastic sub-segment is estimated to touch a value of nearly USD 7,700 million at the end of the year 2021 and is expected to touch a value of nearly USD 12,000 million at the end of the year 2031.
The glass sub-segment is trailing the plastic sub-segment in the material type category and is projected to register a CAGR of 3.8% during the period of assessment.
The glass sub-segment is estimated to be valued at nearly USD 2,450 million in the year 2021 and is expected to touch a value of nearly USD 3,400 million at the end of the period of assessment in the year 2031.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
As a result of the concentration of numerous pharmaceutical glass manufacturing businesses in developed regions like Europe and North America, these areas have well-established supply chains and production systems.
The low labor costs and expanding opportunities offered by these nations, however, are causing manufacturers to relocate their headquarters to nations like Brazil, India, and China. In these nations, the demand for pharmaceutical glass packaging is anticipated to be driven primarily by the generic sector over the forecast period.
For instance, Gennova Biopharmaceuticals, a subsidiary of Indian pharmaceutical company Emcure Pharmaceuticals, began producing the Covid-19 vaccine in February 2022. This vaccine uses mRNA technology to target the Omicron variant. The business intends to request permission from the Drug Controller General of India (DCGI) for the clinical trials of the mRNA vaccine booster shot.
Gerresheimer AG: A global manufacturer of pharmaceutical packaging and drug delivery devices, including vials made of glass and plastic. They offer a variety of services, including design, development, and manufacturing.
Schott AG: Another global company that produces high-quality glass packaging for pharmaceuticals, including vials. They also offer services such as quality control, testing, and customization.
DWK Life Sciences Inc.: A leading manufacturer of laboratory glassware and packaging products, including vials for the pharmaceutical industry. They offer a range of materials, such as glass, plastic, and hybrid vials.
Berry Global Inc.: A key player in the plastic packaging industry, including the production of vials for pharmaceuticals. They offer a range of plastic vials, including those made of PET, PVC, and HDPE.
SGD Pharma: A European company specializing in the production of glass packaging for pharmaceuticals, including vials. They offer various types of vials made of glass, including molded and tubular vials.
The pharmaceutical vials market is slated to attain USD 12,137.2 million in 2023.
The growth potential of the pharmaceutical vials market is 7.1% CAGR through 2033.
Surging demand for injectable drugs and increasing innovation in vial technology.
Gerresheimer AG, Schott AG, and SGD Pharma are the top market players.
Mergers and acquisitions are key strategies consolidating the key players’ position.
1. Executive Summary | Pharmaceutical Vials Market 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Self-Standing 5.2. Round Bottom 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Material Type 6.1. Glass 6.2. Plastic 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Capacity Size 7.1. 0-1ml 7.2. 1-10ml 7.3. 10-50ml 7.4. 50-100ml 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Europe 8.4. Asia Pacific 8.5. MEA 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Key Countries Market Analysis 15. Market Structure Analysis 16. Competition Analysis 16.1. Schott AG 16.2. Gerreshemier AG 16.3. West Pharmaceutical Services, Inc. 16.4. O.BERK COMPANY, LLC 16.5. Adelphi Healthcare Packaging 16.6. Pacific Vial Manufacturing Inc. 16.7. Piramal Glass 16.8. SGD SA 16.9. Stevanato Group S.p.a 16.10. Nipro Europe 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Packaging Insights
View Reports
Pharmaceutical Vials Market
